Literature DB >> 15187164

Down-regulation of IL-2 production in T lymphocytes by phosphorylated protein kinase A-RIIbeta.

Michael R Elliott1, Ryan A Shanks, Islam U Khan, James W Brooks, Pamela J Burkett, Brandy J Nelson, Vasileios Kyttaris, Yuang-Taung Juang, George C Tsokos, Gary M Kammer.   

Abstract

The beta isoform of the type II regulatory subunit (RIIbeta) of protein kinase A suppresses CREB transcriptional activity and c-Fos production in T cells following activation via the TCR. Because CREB is an integral nuclear transcription factor for IL-2 production by T cells, we tested the hypothesis that RIIbeta down-regulates IL-2 expression and IL-2 production in T cells. Stable transfection of RIIbeta in Jurkat T cells led to an approximately 90% reduction in IL-2 mRNA and IL-2 protein following T cell activation. The inhibition of IL-2 production was associated with phosphorylation of the RIIbeta subunit at serine 114 (pRIIbeta) and localization of pRIIbeta in intranuclear clusters. A serine 114 phosphorylation-defective mutant, RIIbeta(S114A), did not form these intranuclear clusters as well as wild-type RIIbeta, and did not inhibit IL-2 mRNA and protein synthesis, indicating that serine 114 phosphorylation is required for both nuclear localization and down-regulation of IL-2 production by RIIbeta. In contrast to its effect on IL-2, RIIbeta induced constitutive up-regulation of CD154 mRNA and cell surface expression. Thus, pRIIbeta differentially regulates gene expression following T cell activation. Unexpectedly, we also found that stable overexpression of another protein kinase A regulatory subunit, RIalpha, had the opposite effect on IL-2 expression, causing a 3- to 4-fold increase in IL-2 production following stimulation. In summary, our data demonstrate a novel mechanism by which serine 114 phosphorylation and nuclear localization of RIIbeta controls the regulation of gene expression in T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187164     DOI: 10.4049/jimmunol.172.12.7804

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Diane C Fingar
Journal:  Lipids       Date:  2010-11-02       Impact factor: 1.880

2.  Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients.

Authors:  William M Lin; Julia M Lewis; Renata B Filler; Badri G Modi; Kacie R Carlson; Swapna Reddy; Adam Thornberg; Gordon Saksena; Sheila Umlauf; Patrick A Oberholzer; Maria Karpova; Gad Getz; Shrikant Mane; Levi A Garraway; Reinhard Dummer; Carole L Berger; Richard L Edelson; Michael Girardi
Journal:  J Invest Dermatol       Date:  2011-09-01       Impact factor: 8.551

3.  Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.

Authors:  Yudong Liu; Ying Su; Shenggang Sun; Tao Wang; Xian Qiao; Hui Li; Xiaoqin Run; Zhihou Liang
Journal:  Neurochem Res       Date:  2012-05       Impact factor: 3.996

4.  Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.

Authors:  Gary M Kammer
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

5.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Authors:  Christina G Katsiari; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.